Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with primary lung cancer (meaning the cancer started in the lung, not spread there from somewhere else)
- People who are receiving care at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center
Who may not be able to join:
- People whose cancer in the lung has spread there from another part of the body (meaning the lung cancer is not the original cancer)
- People diagnosed with mesothelioma (a type of cancer affecting the lining of the lungs)
- People who are considered part of a vulnerable population, such as those who may have difficulty giving informed consent (confirm with trial site for details on how this is defined)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Metabolic polymorphisms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.